CST3 and chronic kidney disease: According to the Kidney Disease: Improving Global Outcomes (KDIGO) guideline for the other cystatin C indications such as borderline eGFRcr between 45 and 74 ml/min/1.73 m2 or persons at high risk of CKD, more subjects might require to be tested for cystatin C (11, 32).